Programmable Bio
India's Agentic Lab
Operating System
LabOS — the agentic operating system for distributed biology. Orchestrating multiomics computation, partner wet labs, and Apollo Hospitals' clinical biobank into closed-loop discovery for India and APAC.
Closed-Loop Discovery Cycles per Quarter
Hypothesis → experiment design → partner-lab execution → validated insight. Every cycle compounds the India Biomarker Atlas and the LabOS experimental graph.
Continue reading
The Strategic Blueprint is structured as six thematic areas. Pick whichever angle is most useful right now.
Overview →
Market context + core strategic thesis. Start here for the macro frame.
Platform →
Why now, the five-agent LabOS mesh, and LIMS integration.
Apollo Moat →
Apollo Hospitals partnership + competitive moat analysis.
Programs →
Reference programs across the drug-development lifecycle.
Strategy →
Build-vs-partner, GTM, KPIs, agentic-lab risk plan.
BioHelix →
Singapore APAC hub. MiRXES partnership. Corridor architecture.
Where to start
Investor / board reader
Macro frame, moat, and unit economics in ~20 minutes.
Pharma BD / R&D lead
Programs, pricing, and reference sprints.
Technical / platform evaluator
Architecture, LIMS wedge, and agentic risk controls.
Two reference sprints
IVD Companion Diagnostics →
18 months / $5M vs $30–50M traditional. Oncology CDx on Apollo cohorts, CDSCO-first with FDA bridging.
Phase 4 Pharmacovigilance →
$2.5M/yr recurring. India-specific PGx signal detection on Apollo EHR + multiomics sub-cohorts.
See hypothetical case studies for end-to-end walkthroughs.